Outcomes of hemodiafiltration based on Japanese dialysis patient registry

American Journal of Kidney Diseases

Volumn 38, Issue 4, 2001, Pages S212-S216

  Nakai, Shigeru ^a   Iseki, Kunitoshi ^a   Tabei, Kaoru ^a   Kubo, Kazuo ^a   Masakane, Ikuto ^a   Fushimi, Kiyohide ^a   Kikuchi, Kenjiro ^a   Shinzato, Toru ^a   Sanaka, Tsutomu ^a   Akiba, Takashi ^a  

^a Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

Author keywords

Amyloidosis; Arthralgia; Hemodiafiltration; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; AGED; AMYLOIDOSIS; ANALYTIC METHOD; CONFERENCE PAPER; FEMALE; HEMADSORPTION; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; MALE; REGISTER; REGRESSION ANALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

AMYLOIDOSIS; COMORBIDITY; DIABETIC NEPHROPATHIES; FEMALE; HEMODIAFILTRATION; HUMANS; JAPAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; QUESTIONNAIRES; REGISTRIES; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 17044442352     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27449     Document Type: Article

References (9)

1. An overview of dialysis treatment in Japan (as of Dec. 31. 1999)
2. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2 microglobulin
3. On-line haemodiafiltration: Remarkable removal of beta2-microglobulin: Long-term clinical observations
4. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
5. An overview of dialysis treatment in Japan (as of Dec. 31, 1998)
6. The Logist procedure
7. A network algorithm for performing Fisher's exact test in rxc contingency tables
8. New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion
9. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients